22
Jul
2010
BioScale, Inc.: Series D $25M
Posted in I - Series D, Q - 2Q10, R - NORTH EAST, X - Device (Diagnostic), X - Device (Protein Assay), XX - MA
BioScale (Cambridge, MA) a commercial-stage therapeutic and diagnostics protein biomarker analytics device company, closed a $25M Series D financing. Participants include Morningside Venture, New Science Ventures, WFD Ventures and F2 Ventures.
OnBioVC PARTNERS
-
